par Ismael, Gustavo ;Rosa, Daniela Dornelles;de Azambuja, Evandro ;Braga, S;Piccart-Gebhart, Martine
Référence Hematology/oncology clinics of North America, 21, 2, page (239-256)
Publication Publié, 2007-04
Référence Hematology/oncology clinics of North America, 21, 2, page (239-256)
Publication Publié, 2007-04
Article révisé par les pairs
Titre: |
|
Auteur: | Ismael, Gustavo; Rosa, Daniela Dornelles; de Azambuja, Evandro; Braga, S; Piccart-Gebhart, Martine |
Informations sur la publication: | Hematology/oncology clinics of North America, 21, 2, page (239-256) |
Statut de publication: | Publié, 2007-04 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Antibodies, Monoclonal -- administration & dosage |
Antibodies, Monoclonal -- adverse effects | |
Antibodies, Monoclonal -- therapeutic use | |
Antineoplastic Agents -- administration & dosage | |
Antineoplastic Agents -- adverse effects | |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- metabolism | |
Breast Neoplasms -- pathology | |
Clinical Trials as Topic | |
Female | |
Humans | |
Neoplasm Staging | |
Receptor, erbB-2 -- biosynthesis | |
Receptor, erbB-2 -- genetics | |
Treatment Outcome | |
Note générale: | Journal Article |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:0889-8588 |
info:doi/10.1016/j.hoc.2007.03.003 | |
info:pii/S0889-8588(07)00019-6 | |
info:scp/34249048896 | |
info:pmid/17512447 |